hemoregulatory peptide 5b has been researched along with Neutropenia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Binder, KA; Moser, MH; Paukovits, JB; Paukovits, WR | 2 |
| Moser, MH; Paukovits, JB; Paukovits, WR; Rutter, R | 1 |
1 review(s) available for hemoregulatory peptide 5b and Neutropenia
| Article | Year |
|---|---|
The use of haemoregulatory peptides (pEEDCK monomer and dimer) for reduction of cytostatic drug induced haemopoietic damage.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Cytarabine; Growth Inhibitors; Hematopoiesis; Hematopoietic Stem Cells; Mice; Neutropenia; Oligopeptides; Polymers; Pyrrolidonecarboxylic Acid | 1990 |
2 other study(ies) available for hemoregulatory peptide 5b and Neutropenia
| Article | Year |
|---|---|
Protection from arabinofuranosylcytosine and n-mustard-induced myelotoxicity using hemoregulatory peptide pGlu-Glu-Asp-Cys-Lys monomer and dimer.
Topics: Animals; Cytarabine; Dose-Response Relationship, Drug; Female; Hematopoietic Stem Cells; Mice; Mice, Inbred BALB C; Mustard Compounds; Myeloproliferative Disorders; Neutropenia; Oligopeptides; Pyrrolidonecarboxylic Acid | 1991 |
Inhibition of hematopoietic stem cell proliferation by hemoregulatory peptide pyroGlu-Glu-Asp-Cys-Lys (pEEDCK) provides protection against short-term neutropenia and long-term damage.
Topics: Animals; Cell Division; Colony-Forming Units Assay; Cytarabine; Growth Inhibitors; Hematopoiesis; Hematopoietic Stem Cells; Kinetics; Mice; Mice, Inbred BALB C; Neutropenia; Oligopeptides; Pyrrolidonecarboxylic Acid | 1991 |